Nutrition & Metabolism,
Год журнала:
2024,
Номер
21(1)
Опубликована: Окт. 11, 2024
Polycystic
ovary
syndrome
(PCOS)
is
a
unity
of
endocrine
and
metabolic
disorders,
associated
with
PI3K/AKT/mTOR,
autophagy,
gut
microbiota.
Quinoa
valuable
food
source,
which
contains
rich
minerals,
unsaturated
fatty
acids,
has
positive
modulating
effect
on
diseases.
However,
its
effects
potential
mechanisms
PCOS
have
not
been
reported
yet.
Therefore,
the
purpose
this
study
to
investigate
quinoa
rats
by
regulating
Ten–week-old
female
Sprague-Dawley
(SD)
received
letrozole
for
24
days
induction
subsequently
were
treated
diet
8
weeks.
Vaginal
smears
used
analyze
estrous
cycle
rats.
Hormone
biochemical
indexes
analyzed
kit
assays
glucometer.
The
pathological
changes
ovary,
pancreas,
duodenum
colon
observed
HE
staining.
PI3K,
AKT,
mTOR
autophagy-related
proteins
in
measured
western
blot
immunohistochemistry
Tight
junction
16
s
rDNA
sequencing
was
detect
intestinal
microbiota
Network
pharmacology
molecular
docking
possible
targets
PCOS.
Spearman
correlation
analysis
relationship
between
microbial
abundance
hormone
levels
at
phylum
genus
level.
significantly
improved
parameters
PCOS-like
rats,
state
tissues.
Especially,
regulated
expression
ovary.
may
repair
barrier
upregulating
tight
colon,
regulate
factors
colon.
Additionally,
increased
Lactobacillu,
Bacteroides
Oscillospira,
decreased
Firmicutes/Bacteroidetes
ratio
Blautia,
Prevotella,
reversing
dysregulation
Correlation
showed
that
there
strong
significant
related
Our
result
indicated
maybe
activation
PI3K/AKT/mTOR
signaling
pathway,
inhibition
regulation
flora.
Biomedicine & Pharmacotherapy,
Год журнала:
2024,
Номер
173, С. 116418 - 116418
Опубликована: Март 9, 2024
Quercetin
is
a
representative
flavonoid
that
widely
present
in
fruits,
herbs,
and
vegetables.
It
also
an
important
active
core
component
traditional
Chinese
medicines.
As
flavonoid,
quercetin
has
various
properties
exerts
antioxidant,
anti-inflammatory,
cardioprotective
effects.
The
public
interest
increasing,
been
used
to
prevent
or
treat
numerous
of
diseases,
such
as
polycystic
ovary
syndrome
(PCOS),
cancer,
autoimmune
diseases
chronic
cardiovascular
clinical
experiments
animal
studies
due
its
powerful
antioxidant
minimal
side
marked
pharmacological
effects
on
gynecological
disorders;
however,
there
have
no
reviews
about
the
potential
health
benefits
context
disorders,
including
PCOS,
premature
failure
(POF),
endometriosis
(EM),
ovarian
cancer
(OC),
cervical
(CC)
endometrial
carcinoma
(EC).
Thus,
this
review
aimed
summarize
biological
disorders
mechanisms.
Scientific Reports,
Год журнала:
2025,
Номер
15(1)
Опубликована: Янв. 9, 2025
As
one
of
the
essential
lignan
derivative
found
in
traditional
Chinese
medicinal
herbs,
secoisolariciresinol
diglucoside
(SDG)
was
proved
to
promote
women's
health
through
its
phytoestrogenic
properties.
Increasingly
studies
indicated
that
this
compound
could
be
a
potential
drug
capable
preventing
estrogen-related
diseases.
Here,
we
aimed
investigate
whether
SDG
can
counteract
cyclophosphamide
(CTX)
induced
premature
ovarian
insufficiency
(POI)
and
further
explore
specific
molecular
mechanism.
In
study,
first
validated
therapeutic
effect
on
POI
mouse
model.
Then,
mechanism
by
which
improves
is
predicted
combination
network
pharmacology,
authenticity
confirmed
experimental
verification,
docking
analysis
dynamics
simulation.
The
results
showed
significantly
alleviated
improving
indices
follicle
counts
while
protecting
against
CTX-induced
damage
modulating
PI3K/Akt
signaling
pathway
KGN
cells.
addition,
SDG's
high
affinity
for
Akt1
PI3Kγ,
pinpointing
precise
interaction
sites.
These
underscore
protective
mechanisms
damage,
highlighting
potential.
summary,
our
study
identified
ameliorate
with
action
intricately
linked
modulation
pathway.
Abstract
Background
and
objective
Early
nutritional
support
holds
paramount
importance
for
postoperative
gastric
cancer
(GC)
patients.
Peptidase
M20
domain
containing
1
(PM20D1)
is
a
secretory
enzyme
associated
with
glucose
lipid
metabolism.
However,
there
dearth
of
clinical
studies
delving
into
the
connection
between
PM20D1,
metabolism,
inflammatory
factors
in
GC
patients
who
have
received
enteral
nutrition
(EN).
This
research
aimed
to
investigate
serum
levels
PM20D1
following
early
EN
their
potential
associations
markers,
factors.
Methods
prospective
observational
study
enrolled
180
May
2020
July
2022.
On
first
day,
all
support,
which
was
maintained
duration
5
days.
Serum
interleukin
(IL)-6,
IL-1β,
C-reactive
protein
were
measured
on
sixth
day
after
surgery
using
an
enzyme-linked
immunosorbent
assay.
Data
demographics,
statistics,
parameters,
prognostic
index
(PNI)
collected.
Patients
followed
up
12
months,
both
overall
survival
disease-free
recorded.
Results
In
low
PNI
group,
albumin
(ALB),
blood
lymphocytes
(BL)
showed
significant
reductions.
Pearson
analysis
revealed
negative
correlation
IL-6
levels,
whereas
positive
emerged
ALB
BL
levels.
Furthermore,
demonstrated
as
biomarker
diagnosing
poor
status
(PNI
<
43)
risk
factor
Conclusion
remarkably
declined
status.
PLoS ONE,
Год журнала:
2024,
Номер
19(10), С. e0311978 - e0311978
Опубликована: Окт. 23, 2024
Primordial
follicle
activation
(PFA)
is
a
pivotal
event
in
female
reproductive
biology,
coordinating
the
transition
from
quiescent
to
growing
follicles.
This
study
employed
comprehensive
single-cell
RNA
sequencing
gain
insights
into
detailed
regulatory
mechanisms
governing
synchronized
dormancy
and
between
granulosa
cells
(GCs)
oocytes
with
progression
of
PFA
process.
Wntless
(
Wls
)
conditional
knockout
(cKO)
mice
served
as
unique
model,
suppressing
pre-GCs
GCs,
disrupting
somatic
cell-derived
WNT
signaling
ovary.
Our
data
revealed
immediate
transcriptomic
changes
GCs
post-PFA
cKO
mice,
leading
divergent
trajectory,
while
exhibited
modest
alterations.
Subpopulation
analysis
identified
molecular
pathways
affected
by
on
GC
maturation,
along
specific
gene
signatures
linked
dormant
activated
oocytes.
Despite
minimal
evidence
continuous
up-regulation
dormancy-related
genes
oocytes,
loss
(pre-)GCs
impacted
expression
even
before
PFA,
subsequently
influencing
them
globally.
The
infertility
observed
was
attributed
compromised
GC-oocyte
crosstalk
microenvironment
for
highlights
role
WNT-signaling
pathway
its
signature,
emphasizing
importance
intercellular
orchestrating
folliculogenesis.
Discovery Medicine,
Год журнала:
2024,
Номер
36(184), С. 946 - 946
Опубликована: Янв. 1, 2024
Polycystic
ovary
syndrome
(PCOS)
commonly
impacts
fertile
females
with
potentially
severe
effects
on
fertility
and
metabolism.
Blood
ghrelin
levels
are
lower
in
PCOS
patients,
exogenous
supplements
have
been
proposed
for
their
potential
to
trigger
anti-inflammatory
at
the
cellular
level.
This
study
aimed
investigate
whether
pretreatment
reduced
inflammation,
insulin
resistance,
reproductive
abnormalities
underlying
mechanism
of
this
disorder.
Biomedicine & Pharmacotherapy,
Год журнала:
2023,
Номер
170, С. 116093 - 116093
Опубликована: Дек. 29, 2023
Polycystic
ovary
syndrome
(PCOS)
is
a
highly
prevalent
endocrine
and
metabolic
disorder
that
closely
associated
with
the
proliferation
apoptosis
of
ovarian
granulosa
cells
(GCs).
Ampelopsis
japonica
(AJ)
dried
tuberous
root
(Thunb.)
Makino
(A.
japonica),
anti-inflammatory,
antioxidant,
antibacterial,
antiviral,
wound-healing,
antitumor
properties;
however,
it
unclear
whether
this
herb
has
therapeutic
effect
on
PCOS.
Therefore,
study
aimed
to
investigate
pharmacological
AJ
PCOS
reveal
its
potential
mechanism
action.
A
rat
model
was
established
using
letrozole.
After
establishing
model,
rats
received
oral
treatment
Diane-35
(Positive
drug:
ethinylestradiol
+
cyproterone
tablets)
for
2
weeks.
Lipidomics
conducted
liquid-phase
mass
spectrometry
chromatography.
significantly
regulated
serum
hormone
levels
attenuated
pathological
variants
in
ovaries
Furthermore,
reduced
apoptotic
rate
GCs.
Lipidomic
analysis
revealed
modulated
glycerolipid
glycerophospholipid
pathways
mediated
by
lipoprotein
lipase
(Lpl),
diacylglycerol
choline
phosphotransferase
(Chpt1),
choline/ethanolamine
(Cept1).
we
may
reduce
GC
modulating
lipid
metabolism,
ultimately
improving
ovulatory
dysfunction
novel
candidate
treatment.